Impairment of Investment Securities Due to Deterioration in Investees’ Financial Condition
First written in FY2021. 1 of 2 entries say "Materialised", first in FY2025. Latest entry: FY2025.
Axel Mark moved to the "Worse" side of this theme in 2025, 5 years after the typical company in this theme (2020).
The whole theme swung hardest in 2019: 37 of 69 companies on the "Worse" side.
40 other companies' latest entry also says "Materialised".
- FY2025MaterialisedAnnual report
「Following careful consideration of the recoverability of the investment in equity-method affiliate Ascella Biosystems, Inc., taking into account its business environment and operating results, the company recognized an equity-method investment loss of ¥112.608 million.」
The company recognized an equity-method investment loss of ¥112.608 million related to Ascella Biosystems, Inc., reflecting the investee’s business environment and operating results. - FY2021First statedAnnual report
「The company holds investment securities in capital and business partners and other investees. Although the Board of Directors seeks to monitor the financial condition and other matters of investees on a quarterly basis, if the value of an investment is impaired due to a sharp deterioration in market conditions, intensifying competition or deterioration in an investee’s financial condition, and the company determines that recovery is unlikely, its financial position and operating results may be affected.」
The company has newly disclosed the risk that the value of investment securities in capital and business partners and other investees may be impaired due to deterioration in an investee’s financial condition, along with the Board of Directors’ quarterly monitoring of their status.